REBECCA ENG: Open Payments
NPI 1265661342 · KENNEWICK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,503 in 90 payments from 15 companies in 2025. Trend: 2023 $1,902 · 2024 $1,780 · 2025 $1,503
Food & beverage: $1,451Education: $53
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $392 |
| Janssen Biotech, Inc. | 19 | $252 |
| UCB, Inc. | 15 | $214 |
| Lilly USA, LLC | 8 | $185 |
| Regeneron Healthcare Solutions, Inc. | 4 | $95 |
| Galderma Laboratories, L.P. | 4 | $73 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $61 |
| LEO Pharma Inc. | 2 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
Products named: TREMFYA, SKYRIZI, Bimzelx, RINVOQ, TALTZ, DUPIXENT, ILUMYA, EBGLYSS.
Industry payments across WA — which companies pay providers there.
